Septerna (SEPN) EBITDA Margin (2023 - 2026)

Septerna's quarterly EBITDA Margin came in at 37.07% in Q1 2026, up 970448.0% year-on-year from N/an in Q1 2025, and down 121.28% quarter-over-quarter from 174.19% in Q4 2025.

Septerna has reported EBITDA Margin for 4 years, with the latest figure at 37.07% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin rose 970448.0% year-over-year to 37.07%; the trailing twelve-month figure through Mar 2026 stood at 21.74% (up 850004.0% YoY), and the FY2025 full-year result was 22.33%, up 749609.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 37.07%, down from 174.19% in the prior quarter.
  • The five-year high for EBITDA Margin was 29082.2% in Q4 2023, with the low at 33166.67% in Q3 2023.
  • Average EBITDA Margin over 4 years is 6061.01%, with a median of 4470.98% recorded in 2024.
  • Peak annual rise in EBITDA Margin reached 2161042 bps in 2024, while the deepest fall reached 4074164 bps in 2024.
  • Tracing SEPN's EBITDA Margin over 4 years: stood at 29082.2% in 2023, then sank by 140 bps to 11659.43% in 2024, then soared by 101 bps to 174.19% in 2025, then plunged by 121 bps to 37.07% in 2026.
  • The last three EBITDA Margin figures came in at 37.07% (Q1 2026), 174.19% (Q4 2025), and 38.95% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -6.43%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 38.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 18.35%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 17.24%
10 Septerna 1.34 Bn 1.34 Bn - -37.07%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -37.07%
Dec 31, 2025 174.19%
Sep 30, 2025 38.95%
Jun 30, 2025 -20,890.76%
Mar 31, 2025 -9,741.55%
Dec 31, 2024 -11,659.43%
Sep 30, 2024 -11,556.25%
Jun 30, 2024 -4,443.78%
Mar 31, 2024 -4,470.98%
Dec 31, 2023 29,082.20%
Sep 30, 2023 -33,166.67%